project . 2016 - 2018 . Closed

CLLassify

Innovative risk assessment for individualizing treatment in chronic lymphocytic leukemia

Open Access mandate for Publications European Commission

Funder: European CommissionProject code: 702714 Call for proposal: H2020-MSCA-IF-2015
Funded under: H2020 | MSCA-IF-EF-ST Overall Budget: 164,653 EURFunder Contribution: 164,653 EUR
Status: Closed
Start Date
01 Apr 2016
End Date
31 Mar 2018
Detailed project information (CORDIS)

Open Access mandate
Research Data: No

Link this project to...

Research outcomes
Deposit your research

Select content type to share

<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=corda__h2020::5e4d03bac7098701fd601eb0cdd58bbf&type=results"></script>');
-->
</script>

For further information contact us at helpdesk@openaire.eu

Download report

Select content type report to download

Summary
Publications
Research Data
Software
Other Research

Description

Chronic lymphocytic leukemia faces high-challenging and timely problems related to the classification and efficient prognosis of patients at the time of diagnosis and the attempt to personalize the treatment. CLLassify addresses these issues in a pioneering fashion within a multidisciplinary collaboration, proposing an improved classification of the patients, based on innovative statistical techniques as well as the novel aspect of personalized prediction of the need for treatment at a specific time point for the individual patient. The statistical background of the applicant, together with the expertise of his supervisor in CLL, guarantee the successful impleme...

Partners

CENTRE FOR RESEARCH AND TECHNOLOGY HELLAS CERTH

Summary

Description

Partners

CENTRE FOR RESEARCH AND TECHNOLOGY HELLAS CERTH

Any information missing or wrong?Report an Issue